.RESEARCH HIGHLIGHT.06 August 2024.
A big randomized controlled trial with cisgender females highlights the difficulties of faithfulness to a regular oral preexposure prophylaxis routine and also illustrates that twice-yearly shot of lenacapavir can keep reliable HIV avoidance amounts over 6 months.